TTYH3 and cervical carcinoma: Additionally, elevated TTYH3 expression was correlated with shorter overall survival in patients with HPV-negative cervical cancer (p = 0.034), patients with HPV-positive cervical cancer (p = 0.016), and all patients with cervical cancer (p = 0.024).